(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol

C19H24N4O — CID 125145329

IUPAC(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol
SMILESO[C@H](CN1CCC(c2c[nH]c3ccccc23)CC1)Cn1cccn1
InChIInChI=1S/C19H24N4O/c24-16(14-23-9-3-8-21-23)13-22-10-6-15(7-11-22)18-12-20-19-5-2-1-4-17(18)19/h1-5,8-9,12,15-16,20,24H,6-7,10-11,13-14H2/t16-/m1/s1
InChIKeyNMPQJXSKXFLPCU-MRXNPFEDSA-N
MW324.43 g/mol
LogP2.60
Rot. Bonds5

About (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol

(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol (PubChem CID 125145329) has the molecular formula C19H24N4O and a molecular weight of 324.43 g/mol. Its IUPAC name is (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol.

Molecular Properties

Compound Name(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol
PubChem CID125145329
Molecular FormulaC19H24N4O
Molecular Weight324.43 g/mol
Exact Mass324.20
IUPAC Name(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol
SMILESO[C@H](CN1CCC(c2c[nH]c3ccccc23)CC1)Cn1cccn1
InChIInChI=1S/C19H24N4O/c24-16(14-23-9-3-8-21-23)13-22-10-6-15(7-11-22)18-12-20-19-5-2-1-4-17(18)19/h1-5,8-9,12,15-16,20,24H,6-7,10-11,13-14H2/t16-/m1/s1
InChIKeyNMPQJXSKXFLPCU-MRXNPFEDSA-N
XLogP2.60
TPSA57.08 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500324.43
LogP ≤ 52.60
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-anilino-3-[4-(1H-indol-3-yl)piperidin-1-yl]propan-2-ol
CID 23392120
(2R)-1-[4-[(R)-hydroxy(phenyl)methyl]piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol
CID 94393943
4-[1-hydroxy-2-[4-(1H-indol-3-yl)piperidin-1-yl]ethyl]piperidin-4-ol
CID 58950812
1-(4-benzylpiperidin-1-yl)-3-pyrazol-1-ylpropan-2-ol
CID 47053104
1-[4-[2-hydroxy-3-[4-(1H-indol-3-yl)piperidin-1-yl]propoxy]phenyl]ethanone
CID 17437228
3-(1-butylpiperidin-4-yl)-1H-indole
CID 21135948
2-[4-(1H-indol-3-yl)piperidin-1-yl]ethanethiol
CID 116997210
2-[4-(1H-indol-3-yl)piperidin-1-yl]-1-[1-(5-phenyl-1,3-oxazol-2-yl)piperidin-4-yl]ethanol
CID 46841569
1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-(2-nitrophenoxy)propan-2-ol;hydrochloride
CID 70491898
methyl 2-[2-hydroxy-3-[4-(1H-indol-3-yl)piperidin-1-yl]propoxy]benzoate
CID 56634055
1-[4-(hydroxymethyl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol
CID 60500592
3-[1-[(1-methylimidazol-2-yl)methyl]piperidin-4-yl]-1H-indole
CID 136580194

Frequently Asked Questions

What is the IUPAC name of (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol?
The IUPAC name of (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol (CID 125145329) is (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol.
What is the SMILES notation for (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol?
The canonical SMILES for (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol is O[C@H](CN1CCC(c2c[nH]c3ccccc23)CC1)Cn1cccn1.
What is the InChIKey of (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol?
The InChIKey is NMPQJXSKXFLPCU-MRXNPFEDSA-N. The full InChI is InChI=1S/C19H24N4O/c24-16(14-23-9-3-8-21-23)13-22-10-6-15(7-11-22)18-12-20-19-5-2-1-4-17(18)19/h1-5,8-9,12,15-16,20,24H,6-7,10-11,13-14H2/t16-/m1/s1.
What are the key properties of (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol?
(2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol has a molecular weight of 324.43 g/mol, XLogP of 2.60, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-1-[4-(1H-indol-3-yl)piperidin-1-yl]-3-pyrazol-1-ylpropan-2-ol is sourced from PubChem (CID 125145329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).